Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery
Key facts
- Who runs it
- Alexandria University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 210 people enrolled
- Started
- 1 May 2025
- Ended
- 1 Dec 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 0.9% normal saline
- Metoclopramide 10mg
- Dexamethasone
- Record updated
- 21 October 2026
Who can take part
- Age
- 40 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age: 40-80 years, both sexes
- ASA physical status class I to III
- Apfel score 0-2
Who cannot take part
- patients taking medications with known antiemetic activity
- previous postoperative vomiting
- history of motion sickness
- patients with gastrointestinal disorders or gastro-oesophageal reflux
- allergy to bupivacaine
- allergy to metoclopramide or dexamethasone
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative nausea and vomiting (PONV) is a common consequence of ambulatory surgery, affecting up to 80% of high-risk patients and 20-30% overall. Despite being widespread, a prior survey found that patients are more averse to PONV than pain and other significant postoperative problems. Furthermore, even mild cases of PONV can have serious repercussions, such as postanesthesia care unit (PACU) workflow disruption, delayed discharges, higher medical costs, and lower patient satisfaction.PONV following intraocular surgery can be unpleasant and may lead to serious complications including suprachoroidal hemorrhage (SCH). SCH is a potentially serious condition that occurs when the posterior ciliary arteries or vortex veins burst, resulting in blood in the suprachoroidal region.
Read full original descriptionShow less
The hypothesis is that dexamethasone will lower the incidence of PONV after cataract surgery when compared with metoclopramide.
The 3 groups in the trial
- group pPlacebo, for comparison
patients will receive 0.9% normal saline
Treatment: 0.9% normal saline
- group MExisting treatment, for comparison
patients will receive 10 mg metoclopramide
Treatment: Metoclopramide 10mg
- group DExisting treatment, for comparison
patients will receive 8 mg dexamethasone
Treatment: Dexamethasone
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery: A Double-blind Randomized Controlled Study
- Record updated
- 21 October 2026